TY - JOUR T1 - Is it time to ACT? A qualitative study of the acceptability and feasibility of Acceptance and Commitment Therapy for adolescents with Chronic Fatigue Syndrome JF - medRxiv DO - 10.1101/2021.04.20.21255804 SP - 2021.04.20.21255804 AU - Philippa Clery AU - Jennifer Starbuck AU - Amanda Laffan AU - Roxanne Parslow AU - Catherine Linney AU - Jamie Leveret AU - Esther Crawley Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/21/2021.04.20.21255804.abstract N2 - Background Paediatric Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is disabling and relatively common. Although evidenced based treatments are available, at least 15% of children remain symptomatic after one year of treatment. Acceptance and Commitment Therapy (ACT) is an alternative therapy option; however, little is known about whether it is an acceptable treatment approach. Our aim was to find out if children who are still disabled by CFS/ME after 12 months of treatment would find ACT acceptable, to inform a randomised controlled trial (RCT) of ACT.Methods We recruited children (diagnosed with CFS/ME; not recovered after one year of treatment; aged 11-17 years), their parent/carer, and healthcare professionals (HCPs) from one specialist UK paediatric CFS/ME service. We conducted semi-structured interviews to explore barriers to recovery; views on current treatments; acceptability of ACT; and feasibility of using an RCT to test effectiveness. Thematic analysis was used to identify patterns in data.Results Twelve adolescents, eleven parents, and seven HCPs were interviewed. All participants thought ACT was acceptable. Participants identified reasons why ACT might be efficacious: pragmatism, acceptance and compassion are valued in chronic illness; values-focussed treatment provides motivation and direction; psychological and physical needs are addressed; normalising difficulties is a useful life-skill. Some adolescents preferred ACT to Cognitive Behavioural Therapy as it encouraged accepting (rather than challenging) thoughts. Most adolescents would consent to an RCT of ACT but a barrier to recruitment was reluctance to randomisation. All HCPs deemed ACT feasible to deliver. Some were concerned patients might confuse ‘acceptance’ with ‘giving up’ and called for clear explanations. All participants thought the timing of ACT should be individualised.Conclusions All adolescents with CFS/ME, parents, and HCPs thought ACT was acceptable, and most adolescents were willing to try ACT. An RCT needs to solve issues around randomisation and timing of the intervention.BOX What is known about the subject?What is known about the subject?Not all young people with CFS/ME recover.ACT is a possible alternative therapy for CFS/ME, which focuses on improving functioning and quality of life rather than symptom reduction.ACT is efficacious in paediatric chronic pain, and preliminary results show promising effects in adults with CFS/ME.What this study adds?What this study adds?ACT is an acceptable therapy for young people with CFS/ME.Participants thought the ‘pragmatic’, ‘compassionate’ and ‘values-based’ focus of ACT would be helpful.Adolescents, parents and healthcare professionals support a randomised controlled trial of ACT.Competing Interest StatementProfessor Crawley acts as a non-paid medical advisor for the Sussex and Kent ME society.Funding StatementPC was employed on the NIHR Academic Foundation Programme at the time of research and is currently supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (Grant code: 204813/Z/16/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London-Brent Ethics Committee approved the study (19/LO/1979).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQualitative data available upon request (if it does not breach anonymity protocol). ER -